author-photo

O. Ashiru

National Institute for Biological Standards and Control

3

Papers

14

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

The chemokine IP10 (CXCL10) dominates the long-term immune response stimulated by BCG treatment of non-muscle invasive bladder cancer, but a high concentration of IP10 in urine is strongly indicative of risk for the development of intolerance to BCG

2018 European Urology Supplements
Show All
- Source
- Cite
- Save
Citations (0)
Characterization of a human anti-tumoral NK cell population expanded after BCG treatment of leukocytes

2017 OncoImmunology
Show All
- Source
- Cite
- Save
Citations (14)
30 CD56 bright natural killer cells primed by innate immune cytokines dominate the immune response stimulated by BCG to non-muscle invasive bladder cancer

2015 European Urology Supplements
Show All
- Source
- Cite
- Save
Citations (0)